Nasdaq Zura News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq zura. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Zura Today - Breaking & Trending Today

Zura Bio (NASDAQ:ZURA) Coverage Initiated at Piper Sandler

Piper Sandler started coverage on shares of Zura Bio (NASDAQ:ZURA – Free Report) in a research report sent to investors on Friday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $26.00 price target on the stock. Separately, Oppenheimer reaffirmed an outperform rating and set a $16.00 price target (down previously from $17.00) […] ....

Amit Munshi , Piper Sandler , Zura Bio , Securities Exchange Commission , Raymond James Associates , Forefront Analytics , York Mellon Corp , Eisler Capital , Free Report , Marketbeat Ratings , Director Amit Munshi , Exchange Commission , New York Mellon Corp , Get Free Report , Bio Limited , Zura Bio Daily , Nasdaq Zura , Initiated Coverage ,

Zura Bio Limited (NASDAQ:ZURA) Director Amit Munshi Purchases 159,744 Shares

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) Director Amit Munshi acquired 159,744 shares of the business’s stock in a transaction that occurred on Monday, April 22nd. The stock was bought at an average cost of $3.13 per share, for a total transaction of $499,998.72. Following the completion of the transaction, the director now directly […] ....

Amit Munshi , Zura Bio , Eisler Capital , Zura Bio Limited , Forefront Analytics , York Mellon Corp , Silverarc Capital Management , Raymond James Associates , Get Free Report , Director Amit Munshi , Bio Limited , New York Mellon Corp , Capital Management , Zura Bio Daily , Nasdaq Zura , Insider Trading , Nsider Trades ,

Zura Bio Limited (NASDAQ:ZURA) Insider Buys $24,999.31 in Stock

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) insider Michael Howell purchased 7,987 shares of the company’s stock in a transaction on Monday, April 22nd. The stock was acquired at an average price of $3.13 per share, with a total value of $24,999.31. Following the purchase, the insider now owns 7,987 shares of the company’s […] ....

Michael Howell , Zura Bio , Zura Bio Limited , York Mellon Corp , Raymond James Associates , Eisler Capital , Forefront Analytics , Get Free Report , New York Mellon Corp , Bio Limited , Zura Bio Daily , Nasdaq Zura , Insider Trading , Nsider Trades ,

Replimune Group (NASDAQ:REPL) and Zura Bio (NASDAQ:ZURA) Head-To-Head Comparison

Zura Bio (NASDAQ:ZURA – Get Free Report) and Replimune Group (NASDAQ:REPL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Insider & Institutional Ownership 61.1% of Zura […] ....

United States , Zura Bio , Replimune Group Inc , Replimune Group , Get Free Report , Given Zura Bio , Bio Limited , Zura Bio Daily , Nasdaq Zura , Stock Comparison , Stock Analysis ,

Zura Bio (NASDAQ:ZURA) Rating Reiterated by Oppenheimer

Zura Bio (NASDAQ:ZURA – Get Free Report)‘s stock had its “outperform” rating reiterated by equities research analysts at Oppenheimer in a research note issued to investors on Monday, Benzinga reports. They presently have a $16.00 price objective on the stock, down from their previous price objective of $17.00. Zura Bio Stock Up 0.4 % NASDAQ:ZURA […] ....

United States , Zura Bio , Raymond James Associates , Zura Bio Company Profile , American International Group Inc , Jpmorgan Chase Co , Forefront Analytics , Get Free Report , International Group , Raymond James , Bio Limited , Zura Bio Daily , Nasdaq Zura , Reiterated Rating , Oppenheimer Holdings Inc ,